Accelerate Diagnostics reports Q3 2018 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Accelerate Diagnostics (AXDX) Reports In-Line Q3 EPS
November 6, 2018 4:45 PM ESTAccelerate Diagnostics (NASDAQ: AXDX) reported Q3 EPS of ($0.41), in-line with the analyst estimate of ($0.41). Revenue for the quarter came in at $1.36 million versus the consensus estimate of $2.95 million.
For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.
... More